Difference between revisions of "Part:BBa K5366064"

 
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
  
 
__NOTOC__
 
__NOTOC__
−
<partinfo>BBa_K5366064 short</partinfo>
+
<partinfo>BBa_K5366042 short</partinfo>
−
 
+
−
AJC 7 triple point mutation expression plasmid
+
  
 +
AJC7 triple point mutant
 +
<h1>Construction</h1>
 +
1. Plasmid Construction
 +
S125D point mutation primers were designed, and PCR was performed using pET-28a(+)-AJC7 as a template for the mutation (Fig. 1). Following the PCR reaction, demethylation was carried out using DpnI. To verify the mutations, 5 μL of the reaction mixture was taken for analysis by nucleic acid gel electrophoresis. After confirming the correctness of the PCR product, the product was recovered to obtain the single point mutant plasmid.
 +
The concentration of the single-site mutant plasmid was measured, and it was subsequently transformed into <i>E. coli</i> BL21 (DE3) competent cells. The cells were incubated in an inverted culture at 37°C for 14 hours. Single colonies were selected from the transformed colonies, and colony PCR was performed. After verification through nucleic acid electrophoresis, the corresponding single colonies displaying the correct bands were transferred to LB (Kan) liquid medium for preservation. This completed the S125D single-site mutation step.
 +
After successfully obtaining the S125D single-point mutant plasmid, this plasmid was further mutated to construct the S125D/T181A two-point mutant plasmid, following the same steps as for the single-point mutation. Next, the S125D/T181A two-point mutant plasmid underwent additional mutation to create the S125D/T181A/L140P three-point mutant plasmid. This final plasmid was then transferred to <i>E. coli </i>BL21 (DE3) competent cells for verification via nucleic acid electrophoresis (Figure 2). Verification results are presented in Figure 2.
 +
<html>
 +
<style>
 +
    .bild {max-width: 60% ; height: auto;}
 +
</style>
 +
<p>
 +
  <img class="bild" src="https://static.igem.wiki/teams/5366/part/fig-1-mapping-of-mutant-plasmids42.png"><br>
 +
  <i><b> Fig.1 Mapping of mutant plasmids <br><br></b></I>
 +
  <div class="unterschrift"><bFig. 1 Construction of pMTL-Pfba-Bs2 recombinant plasmid</b>
 +
  </div>
 +
</p>
 +
</html>
 +
<html>
 +
<style>
 +
    .bild {max-width: 60% ; height: auto;}
 +
</style>
 +
<p>
 +
  <img class="bild" src="https://static.igem.wiki/teams/5366/part/part-2/fig-2-nucleic-acid-gel-diagram-of-colony-pcr-sandian42.png"><br>
 +
  <i><b> Fig.2 Nucleic acid gel diagram of colony PCR <br><br></b></I>
 +
  <div class="unterschrift"><bFig. 1 Construction of pMTL-Pfba-Bs2 recombinant plasmid</b>
 +
  </div>
 +
</p>
 +
</html>
 +
2. Product Analysis
 +
The mutant and wild-type strains were activated, cultured for amplification, and subjected to a series of protein purification operations to extract the target proteins, as outlined in the [Experimental] section. The volume of the purified enzyme solution required for the 500 μL reaction system was determined based on the protein concentration specified in [Experimental]. The final fructose concentration in the reaction system was set at 100 g/L, and 10 µL of Ni<sup>2+</sup> was included as a catalyst. The reaction was conducted at 70°C for 5 hours, after which the products were analyzed using High-Performance Liquid Chromatography (HPLC) (Figure 3).
 +
<h1>Result</h1>
 +
To enhance substrate transformation capabilities, we introduced a three-point mutation (S125D/T181A/L140P) into AJC7. The results indicated that the product concentrations for this triple mutant were higher compared to the wild-type enzyme. However, its effectiveness was somewhat reduced when compared to the optimal two-point mutant.
 +
<html>
 +
<style>
 +
    .bild {max-width: 60% ; height: auto;}
 +
</style>
 +
<p>
 +
  <img class="bild" src="https://static.igem.wiki/teams/5366/part/part-2/sandian-h3.png"><br>
 +
  <i><b> Fig.3 The concentrations of tagatose in wild-type, S125D, S125D/T181A, S125D/T181A/L140P, and S125D/T181A/H342L reacted with 100 g/L fructose substrate for 5 h, respectively <br><br></b></I>
 +
  <div class="unterschrift"><bFig. 1 Construction of pMTL-Pfba-Bs2 recombinant plasmid</b>
 +
  </div>
 +
</p>
 +
</html>
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here
 
===Usage and Biology===
 
===Usage and Biology===
Line 10: Line 51:
 
<!-- -->
 
<!-- -->
 
<span class='h3bb'>Sequence and Features</span>
 
<span class='h3bb'>Sequence and Features</span>
−
<partinfo>BBa_K5366064 SequenceAndFeatures</partinfo>
+
<partinfo>BBa_K5366042 SequenceAndFeatures</partinfo>
  
  
 
<!-- Uncomment this to enable Functional Parameter display  
 
<!-- Uncomment this to enable Functional Parameter display  
 
===Functional Parameters===
 
===Functional Parameters===
−
<partinfo>BBa_K5366064 parameters</partinfo>
+
<partinfo>BBa_K5366042 parameters</partinfo>
 
<!-- -->
 
<!-- -->

Latest revision as of 13:50, 28 September 2024


AJC7/S125D/T181A/ L140P

AJC7 triple point mutant

Construction

1. Plasmid Construction S125D point mutation primers were designed, and PCR was performed using pET-28a(+)-AJC7 as a template for the mutation (Fig. 1). Following the PCR reaction, demethylation was carried out using DpnI. To verify the mutations, 5 μL of the reaction mixture was taken for analysis by nucleic acid gel electrophoresis. After confirming the correctness of the PCR product, the product was recovered to obtain the single point mutant plasmid. The concentration of the single-site mutant plasmid was measured, and it was subsequently transformed into E. coli BL21 (DE3) competent cells. The cells were incubated in an inverted culture at 37°C for 14 hours. Single colonies were selected from the transformed colonies, and colony PCR was performed. After verification through nucleic acid electrophoresis, the corresponding single colonies displaying the correct bands were transferred to LB (Kan) liquid medium for preservation. This completed the S125D single-site mutation step. After successfully obtaining the S125D single-point mutant plasmid, this plasmid was further mutated to construct the S125D/T181A two-point mutant plasmid, following the same steps as for the single-point mutation. Next, the S125D/T181A two-point mutant plasmid underwent additional mutation to create the S125D/T181A/L140P three-point mutant plasmid. This final plasmid was then transferred to E. coli BL21 (DE3) competent cells for verification via nucleic acid electrophoresis (Figure 2). Verification results are presented in Figure 2.


Fig.1 Mapping of mutant plasmids


Fig.2 Nucleic acid gel diagram of colony PCR

2. Product Analysis The mutant and wild-type strains were activated, cultured for amplification, and subjected to a series of protein purification operations to extract the target proteins, as outlined in the [Experimental] section. The volume of the purified enzyme solution required for the 500 μL reaction system was determined based on the protein concentration specified in [Experimental]. The final fructose concentration in the reaction system was set at 100 g/L, and 10 µL of Ni2+ was included as a catalyst. The reaction was conducted at 70°C for 5 hours, after which the products were analyzed using High-Performance Liquid Chromatography (HPLC) (Figure 3).

Result

To enhance substrate transformation capabilities, we introduced a three-point mutation (S125D/T181A/L140P) into AJC7. The results indicated that the product concentrations for this triple mutant were higher compared to the wild-type enzyme. However, its effectiveness was somewhat reduced when compared to the optimal two-point mutant.


Fig.3 The concentrations of tagatose in wild-type, S125D, S125D/T181A, S125D/T181A/L140P, and S125D/T181A/H342L reacted with 100 g/L fructose substrate for 5 h, respectively

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 501
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 1003
  • 1000
    COMPATIBLE WITH RFC[1000]